These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 7797031)

  • 1. Screening for hemochromatosis.
    Kushner JP
    Gastroenterology; 1995 Jul; 109(1):315-6. PubMed ID: 7797031
    [No Abstract]   [Full Text] [Related]  

  • 2. Screening blood donors for hereditary hemochromatosis: decision analysis model based on a 30-year database.
    Adams PC; Gregor JC; Kertesz AE; Valberg LS
    Gastroenterology; 1995 Jul; 109(1):177-88. PubMed ID: 7797016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for hemochromatosis?
    Lederle FA
    J Gen Intern Med; 1989; 4(1):61-3. PubMed ID: 2915275
    [No Abstract]   [Full Text] [Related]  

  • 4. Screening for hemochromatosis in children of homozygotes: prevalence and cost-effectiveness.
    Adams PC; Kertesz AE; Valberg LS
    Hepatology; 1995 Dec; 22(6):1720-7. PubMed ID: 7489980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haemochromatosis and type 2 diabetes.
    Aldersley MA; Allgar V; Howdle PD; Markham AF
    Lancet; 1998 Sep; 352(9133):1067-8. PubMed ID: 9759782
    [No Abstract]   [Full Text] [Related]  

  • 6. Screening for hemochromatosis: a cost-effectiveness study based on 12,258 patients.
    Balan V; Baldus W; Fairbanks V; Michels V; Burritt M; Klee G
    Gastroenterology; 1994 Aug; 107(2):453-9. PubMed ID: 8039622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Genetic hemochromatosis: importance of population screening?].
    Cartabellotta A; Montalto G
    Recenti Prog Med; 1996 Mar; 87(3):118-23. PubMed ID: 8650432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of hemochromatosis among 11,065 presumably healthy blood donors.
    Edwards CQ; Griffen LM; Goldgar D; Drummond C; Skolnick MH; Kushner JP
    N Engl J Med; 1988 May; 318(21):1355-62. PubMed ID: 3367936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness analysis for evaluation of screening programs: hereditary hemochromatosis.
    Buffone GJ; Beck JR
    Clin Chem; 1994 Aug; 40(8):1631-6. PubMed ID: 8045021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hemochromatosis--molecular genetic screening of blood donors?].
    Tranebjaerg L
    Tidsskr Nor Laegeforen; 1998 Aug; 118(19):2993-5. PubMed ID: 9748841
    [No Abstract]   [Full Text] [Related]  

  • 11. Hemochromatosis screening in asymptomatic ambulatory men 30 years of age and older.
    Baer DM; Simons JL; Staples RL; Rumore GJ; Morton CJ
    Am J Med; 1995 May; 98(5):464-8. PubMed ID: 7733125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening blood donors for hereditary hemochromatosis: decision analysis model comparing genotyping to phenotyping.
    Adams PC; Valberg LS
    Am J Gastroenterol; 1999 Jun; 94(6):1593-600. PubMed ID: 10364030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Screening in primary health care. Presentation of a case of familial hemochromatosis].
    Ibáñez Estella JA; Sánchez Ibáñez A; Rubio Montañés ML; Malumbres Juarros P; Izquierdo Clemente C
    An Med Interna; 1992 Oct; 9(10):516. PubMed ID: 1420767
    [No Abstract]   [Full Text] [Related]  

  • 14. Importance of establishing appropriate local reference values for the screening of hemochromatosis: a study of three different control populations and 136 hemochromatosis family members. Hemochromatosis Clinical and Research Group.
    Porto G; Vicente C; Fraga J; da Silva BM; de Sousa M
    J Lab Clin Med; 1992 Mar; 119(3):295-305. PubMed ID: 1541878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upstream like a salmon (early diagnosis of hemochromatosis).
    Barlow JF
    S D J Med; 1997 Jan; 50(1):7. PubMed ID: 9029987
    [No Abstract]   [Full Text] [Related]  

  • 16. Screening for hemochromatosis: phenotype versus genotype.
    Edwards CQ; Griffen LM; Ajioka RS; Kushner JP
    Semin Hematol; 1998 Jan; 35(1):72-6. PubMed ID: 9460810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for hereditary haemochromatosis within families and beyond.
    McCune CA; Ravine D; Worwood M; Jackson HA; Evans HM; Hutton D
    Lancet; 2003 Dec; 362(9399):1897-8. PubMed ID: 14667749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Should we screen for hemochromatosis? Critical analysis of the literature].
    Charvet-Protat S; Yaouanq J; Fleurette F
    Rev Epidemiol Sante Publique; 1997 Sep; 45(4):315-27. PubMed ID: 9380912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Why do people choose not to have screening for hemochromatosis?
    Wolthuizen M; Nisselle A; Halliday J; Metcalfe SA; Aitken M; Allen KJ; Delatycki MB
    Genet Test Mol Biomarkers; 2013 Jan; 17(1):21-4. PubMed ID: 23098241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of screening for hereditary hemochromatosis.
    Phatak PD; Guzman G; Woll JE; Robeson A; Phelps CE
    Arch Intern Med; 1994 Apr; 154(7):769-76. PubMed ID: 8147681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.